sotorasib,docetaxel
sanofi,aventis,amgen
['docetaxel', 'codebreak 200', 'nsclc', 'sotorasib', 'sclc']
looking forward to hearing outcomes from the phase 3 codebreak 200 study investigating sotorasib vs. docetaxel for kras g12c mutant advanced nsclc tomorrow! #esmo22 
Free, independent education to support healthcare professionals in oncology. Our interactive resources are localised, translated and CME-accredited. Join today!